Atlas Trials

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

Clinical trial NCT00623480 · COMPLETED

Trial details

NCT number
NCT00623480
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hemophilia A
Start date
2008-03-01
Primary completion
2011-09-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.